CytRx Corporation to Present at the Jefferies 2nd Annual Healthcare Conference
LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq: CYTR - News), a biopharmaceutical company engaged in the development and commercialization of human therapeutics, today announced that Steven A. Kriegsman, President and Chief Executive Officer, will be presenting at the Jefferies 2nd Annual Healthcare Conference on Thursday, June 26, 2008, at 11:15 a.m. EDT (8:15 a.m. PDT) in New York City.
ADVERTISEMENT
The presentation will include information about CytRx’s pipeline and its planned acquisition of Innovive Pharmaceuticals.
An audio Webcast of the presentation will be available at www.wsw.com/webcast/jeff26/cytr as well as through the Company’s Web site at www.cytrx.com, where a replay will also be available for 90 days following the conference.
About CytRx Corporation
CytRx Corporation is a biopharmaceutical research and development company engaged in the development of high-value human therapeutics. The Company has three clinical-stage development programs based on its small-molecule “molecular chaperone” co-induction technology. CytRx owns and operates a research and development facility in San Diego. The Company has also recently signed a definitive agreement to acquire Innovive Pharmaceuticals, Inc., a biopharmaceutical company with a pipeline of attractive oncology therapeutic drug candidates. CytRx also maintains a 49 percent equity interest in RXi Pharmaceuticals (Nasdaq: RXII - News). For more information on the Company, visit www.cytrx.com
All posts are only my opinion and are not buy or sell recommendations.
AI
